Contango also only took $400k of the $14.6m raise - that's a lot of new money coming in at 6.2c, which isn't here for a 10% rise imo.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling